Provided by Tiger Fintech (Singapore) Pte. Ltd.

Caribou Biosciences

1.81
-0.0700-3.72%
Post-market: 1.79-0.0200-1.10%19:19 EDT
Volume:1.14M
Turnover:2.11M
Market Cap:168.34M
PE:-1.12
High:1.92
Open:1.89
Low:1.79
Close:1.88
52wk High:3.00
52wk Low:0.6600
Shares:93.00M
Float Shares:83.94M
Volume Ratio:0.91
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6220
EPS(LYR):-1.6509
ROE:-52.76%
ROA:-29.21%
PB:0.77
PE(LYR):-1.10

Loading ...

BRIEF-EV Owners Save Most on Auto Loan Refinancing, Caribou Finds—Time to Stack EV & OBBBA Benefits Before Tax Credits End

Reuters
·
Yesterday

Government Support May Be Fading, but Refi Deals for Evs Are Heating up: New Caribou Data Reveals Electric Vehicle Owners Save the Most by Refinancing Auto Loans--With a Unique Chance to Stack Obbba and EV Savings Before Tax Credits End

THOMSON REUTERS
·
Yesterday

Caribou Biosciences Inc expected to post a loss of 39 cents a share - Earnings Preview

Reuters
·
Jul 31

Caribou Biosciences Regains Nasdaq Compliance Following Stock Price Recovery

Reuters
·
Jun 23

Caribou Biosciences Confirms Director Elections and Auditor

TIPRANKS
·
Jun 14

Caribou Biosciences Inc. Conducted Annual Stockholders Meeting

Reuters
·
Jun 14

Precision BioSciences Reports Sharp Revenue Decline in Q1 2025 with Less Than $0.1M from Previous $17.6M

Reuters
·
May 15

Caribou Biosciences (CRBU) Receives a Hold from Evercore ISI

TIPRANKS
·
May 13

RBC Lowers Price Target on Caribou Biosciences to $10 From $11, Keeps Outperform, Speculative Risk

MT Newswires Live
·
May 09

Caribou Biosciences Inc Files For Mixed Shelf Of Up To $300 Million - SEC Filing

Reuters
·
May 09

Caribou Biosciences Q1 EPS $(0.43) Beats $(0.44) Estimate, Sales $2.35M Beat $1.75M Estimate

Benzinga
·
May 09

BRIEF-Caribou Biosciences Q1 Basic EPS USD -0.43

Reuters
·
May 09

Will Caribou Biosciences, Inc. (CRBU) Report Negative Q1 Earnings? What You Should Know

Zacks
·
Apr 29

Caribou Biosciences price target lowered to $3 from $9 at H.C. Wainwright

TIPRANKS
·
Apr 28

BUZZ-Caribou Biosciences rises on job cuts, shifts focus to cancer therapies

Reuters
·
Apr 25

BRIEF-Caribou Biosciences Announces Strategic Pipeline Prioritization with Focus on CB-010 and CB-011 Oncology Programs

Reuters
·
Apr 25

Caribou Biosciences Cuts Workforce, Shifts Pipeline to Focus on Key Oncology Programs

Dow Jones
·
Apr 25

908 Devices Leads These 3 Penny Stocks To Consider

Simply Wall St.
·
Apr 10

Truist Removes Price Target on Caribou Biosciences, Keeps Buy Rating; Price Target Was $19

MT Newswires Live
·
Mar 20

Caribou Biosciences Price Target Maintained With a $9.00/Share by HC Wainwright & Co.

Dow Jones
·
Mar 19